Schacterle Amy
SEC insider (Form 3/4/5 filer). CIK 0002042021. Chief Regulatory Officer at Acumen Pharmaceuticals, Inc. (ABOS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 16, 2026. Located in NEWTON, MA.
Companies Schacterle Amy has filed insider reports for
- Acumen Pharmaceuticals, Inc. (ABOS): Officer, Chief Regulatory Officer
Schacterle Amy
CIK: 0002042021
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABOS
Acumen Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 16, 2026ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect84.6K shares- - Jan 7, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect1.1K shares at avg. $1.98$2K - Jan 6, 2025ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect8.8K shares- - Nov 5, 2024ABOS
Acumen Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (right to buy)
340K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Award | 84,600 | - | $0 | Direct |
| Jan 7, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 1,097 | $1.98 | $2,176 | Direct |
| Jan 6, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Award | 8,800 | - | $0 | Direct |
| Nov 5, 2024 | ABOS Acumen Pharmaceuticals, Inc. | Award Employee Stock Option (right to buy) | 340,000 | - | - | Direct |
1-4 of 4 transactions